Compare WVE & FFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | FFBC |
|---|---|---|
| Founded | 2012 | 1863 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2015 | N/A |
| Metric | WVE | FFBC |
|---|---|---|
| Price | $12.65 | $30.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $30.44 | $29.50 |
| AVG Volume (30 Days) | ★ 3.2M | 1.2M |
| Earning Date | 03-03-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 3.30% |
| EPS Growth | N/A | ★ 10.83 |
| EPS | N/A | ★ 2.66 |
| Revenue | $109,230,000.00 | ★ $861,817,000.00 |
| Revenue This Year | N/A | $26.94 |
| Revenue Next Year | $16.10 | $4.48 |
| P/E Ratio | ★ N/A | $11.39 |
| Revenue Growth | ★ 103.75 | 13.99 |
| 52 Week Low | $5.28 | $21.10 |
| 52 Week High | $21.73 | $31.38 |
| Indicator | WVE | FFBC |
|---|---|---|
| Relative Strength Index (RSI) | 41.05 | 67.86 |
| Support Level | $12.51 | $29.66 |
| Resistance Level | $14.15 | $31.38 |
| Average True Range (ATR) | 0.76 | 0.98 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 8.29 | 75.77 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.